SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sarah Winter, Sylvie Fasola, Hervé Brisse, Véronique Mosseri, Daniel Orbach, Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second-line chemotherapy, Pediatric Blood & Cancer, 2015, 62, 9
  2. 2
    Jörg Thomas Hartmann, R. D. Issels, K. San Nicolo, V. Grünwald, B. Hertenstein, E. Papesch, S. Krause, I. Sturm, Topotecan plus cyclophosphamide in adults with relapsed or refractory pediatric-type sarcoma: a retrospective analysis from the German Sarcoma Medical Oncology Group (AIO), Investigational New Drugs, 2015,

    CrossRef

  3. 3
    Nadège Corradini, Françoise Redini, Bone Cancer, 2015,

    CrossRef

  4. 4
    B. Morland, K. Platt, J.S. Whelan, A phase II window study of irinotecan (CPT-11) in high risk ewing sarcoma: A Euro-E.W.I.N.G. study, Pediatric Blood & Cancer, 2014, 61, 3
  5. 5
    Jong Yoon, Mi Kwon, Hyeon Park, Seog Park, Kun Lim, Jungnam Joo, Byung-Kiu Park, A study of docetaxel and irinotecan in children and young adults with recurrent or refractory Ewing sarcoma family of tumors, BMC Cancer, 2014, 14, 1, 622

    CrossRef

  6. 6
    Robin E. Norris, Suzanne Shusterman, Lia Gore, Jodi A. Muscal, Margaret E. Macy, Elizabeth Fox, Noah Berkowitz, Aby Buchbinder, Rochelle Bagatell, Phase 1 evaluation of EZN-2208, a polyethylene glycol conjugate of SN38, in children adolescents and young adults with relapsed or refractory solid tumors, Pediatric Blood & Cancer, 2014, 61, 10
  7. 7
    Claire Verschraegen, Sujana Movva, Yongli Ji, Berndt Schmit, Robert Quinn, Ben Liem, Therese Bocklage, Monte Shaheen, A Phase I Study of the Combination of Temsirolimus with Irinotecan for Metastatic Sarcoma, Cancers, 2013, 5, 2, 418

    CrossRef

  8. 8
    Parth S. Mehta, John T. Wiernikowski, J A. Sergio Petrilli, Ronald D. Barr, Essential medicines for pediatric oncology in developing countries, Pediatric Blood & Cancer, 2013, 60, 5
  9. 9
    K. Okada, K. Yamasaki, C. Tanaka, H. Fujisaki, Y. Osugi, J. Hara, Phase I Study of Bevacizumab Plus Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors, Japanese Journal of Clinical Oncology, 2013, 43, 11, 1073

    CrossRef

  10. 10
    Patrick J. Grohar, Lee J. Helman, Prospects and challenges for the development of new therapies for Ewing sarcoma, Pharmacology & Therapeutics, 2013, 137, 2, 216

    CrossRef

  11. 11
    Lisa M. McGregor, Clinton F. Stewart, Kristine R. Crews, Michael Tagen, Amy Wozniak, Jianrong Wu, M. Beth McCarville, Fariba Navid, Victor M. Santana, Peter J. Houghton, Wayne L. Furman, Carlos Rodriguez-Galindo, Dose escalation of intravenous irinotecan using oral cefpodoxime: A phase I study in pediatric patients with refractory solid tumors, Pediatric Blood & Cancer, 2012, 58, 3
  12. 12
    H. Mrabti, W. Kaikani, N. Ahbeddou, H. Abahssain, B. El Khannoussi, M. Amrani, H. Errihani, Metastatic Desmoplastic Small Round Cell Tumor Controlled by an Anthracycline-Based Regimen: Review of the Role of Chemotherapy, Journal of Gastrointestinal Cancer, 2012, 43, 1, 103

    CrossRef

  13. 13
    Véronique Minard-Colin, Jean-Laurent Ichante, Laurent Nguyen, Angelo Paci, Daniel Orbach, Christophe Bergeron, Anne-Sophie Defachelles, Nicolas André, Nadège Corradini, Claudine Schmitt, Marie-Dominique Tabone, Pascale Blouin, Nicolas Sirvent, Gisele Goma, Birgit Geoerger, Odile Oberlin, Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour: Good tolerance profile and efficacy in rhabdomyosarcoma – A report from the Société Française des Cancers et leucémies de l’Enfant et de l’adolescent (SFCE), European Journal of Cancer, 2012, 48, 15, 2409

    CrossRef

  14. 14
    Lars Wagner, Camptothecin-Based Regimens for Treatment of Ewing Sarcoma: sPast Studies and Future Directions, Sarcoma, 2011, 2011, 1

    CrossRef

  15. 15
    Vinita Pai, Kyle Porter, Mark Ranalli, Octreotide acetate is efficacious and safe in children for treating diarrhea due to chemotherapy but not acute graft versus host disease, Pediatric Blood & Cancer, 2011, 56, 1
  16. 16
    Carolin Hartmann, Peter Weinel, Hansjörg Schmid, Lorenz Grigull, Anette Sander, Christin Linderkamp, Karl Welte, Dirk Reinhardt, Oxaliplatin, Irinotecan, and Gemcitabine, Journal of Pediatric Hematology/Oncology, 2011, 33, 5, 344

    CrossRef

  17. 17
    Michela Casanova, Andrea Ferrari, Pharmacotherapy for pediatric soft-tissue sarcomas, Expert Opinion on Pharmacotherapy, 2011, 12, 4, 517

    CrossRef

  18. 18
    Serhan Küpeli, Kudret Çağlar, Dilek Birgen, Arzu Sungur, Ali Varan, Desmoplastic Small Round Cell Tumor of the Mandible in a Child With Unusual Plantar Metastasis, Journal of Pediatric Hematology/Oncology, 2010, 32, 4, e155

    CrossRef

  19. 19
    Muna Qayed, Christie Powell, Elaine R. Morgan, Maureen Haugen, Howard M. Katzenstein, Irinotecan as maintenance therapy in high-risk hepatoblastoma, Pediatric Blood & Cancer, 2010, 54, 5
  20. 20
    Gianni Bisogno, Riccardo Riccardi, Angela Scagnellato, Giampaolo Arcamone, Lucia Miglionico, Modesto Carli, No effect of irinotecan in patients with resistant desmoplastic small round cell tumor, Pediatric Blood & Cancer, 2010, 54, 1
  21. 21
    Lars M. Wagner, John P. Perentesis, Joel M. Reid, Matthew M. Ames, Stephanie L. Safgren, Marvin D. Nelson, Ashish M. Ingle, Susan M. Blaney, Peter C. Adamson, Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: A Children's Oncology Group phase I consortium study, Pediatric Blood & Cancer, 2010, 54, 4
  22. 22
    Iyad Sultan, Andrea Ferrari, Selecting multimodal therapy for rhabdomyosarcoma, Expert Review of Anticancer Therapy, 2010, 10, 8, 1285

    CrossRef

  23. 23
    Adam S. Levy, Paul A. Meyers, Leonard H. Wexler, Regina Jakacki, Anne Angiolillo, Sarah N. Ringuette, Marvin B. Cohen, Richard Gorlick, Phase 1 and pharmacokinetic study of concurrent carboplatin and irinotecan in subjects aged 1 to 21 years with refractory solid tumors, Cancer, 2009, 115, 1
  24. 24
    Stephen L. Lessnick, A. Paolo Dei Tos, Poul H.B. Sorensen, Palma Dileo, Laurence H. Baker, Stefano Ferrari, Kirsten Sundby Hall, Small Round Cell Sarcomas, Seminars in Oncology, 2009, 36, 4, 338

    CrossRef

  25. 25
    Fredrik Mertens, Cristina R. Antonescu, Peter Hohenberger, Marc Ladanyi, Piergiorgio Modena, Maurizio D'Incalci, Paolo G. Casali, Massimo Aglietta, Thor Alvegård, Translocation-Related Sarcomas, Seminars in Oncology, 2009, 36, 4, 312

    CrossRef

  26. 26
    Ian J. Davis, Antonio R. Perez-Atayde, David E. Fisher, Oncology of Infancy and Childhood, 2009,

    CrossRef

  27. 27
    Frederic G. Barr, Richard B. Womer, Oncology of Infancy and Childhood, 2009,

    CrossRef

  28. 28
    C.E. Stuart-Buttle, C.J. Smart, S. Pritchard, D. Martin, I.M. Welch, Desmoplastic small round cell tumour: A review of literature and treatment options, Surgical Oncology, 2008, 17, 2, 107

    CrossRef

  29. 29
    Kevin C. De Braganca, Roger J. Packer, Neurotoxicity of chemotherapeutic and biologic agents in children with cancer, Current Neurology and Neuroscience Reports, 2008, 8, 2, 114

    CrossRef

  30. 30
    Dolly Aguilera, Andrea Hayes-Jordan, Peter Anderson, Shiao Woo, Margaret Pearson, Holly Green, Outpatient and Home Chemotherapy with Novel Local Control Strategies in Desmoplastic Small Round Cell Tumor, Sarcoma, 2008, 2008, 1

    CrossRef

  31. 31
    Lars M. Wagner, Kristine R. Crews, Clinton F. Stewart, Carlos Rodriguez-Galindo, Rene Y. McNall-Knapp, Karen Albritton, Alberto S. Pappo, Wayne L. Furman, Reducing irinotecan-associated diarrhea in children, Pediatric Blood & Cancer, 2008, 50, 2
  32. 32
    Henk van den Berg, Biology and treatment of malignant solid tumors in childhood, Update on Cancer Therapeutics, 2007, 2, 4, 177

    CrossRef

  33. 33
    P. Reichardt, O.S. Nielsen, S. Bauer, J.T. Hartmann, P. Schöffski, T.B. Christensen, D. Pink, S. Daugaard, S. Marreaud, M. Van Glabbeke, J.Y. Blay, Exatecan in pretreated adult patients with advanced soft tissue sarcoma: Results of a phase II – Study of the EORTC Soft Tissue and Bone Sarcoma Group, European Journal of Cancer, 2007, 43, 6, 1017

    CrossRef

  34. 34
    Bernd Kasper, Thierry Gil, Veronique D’Hondt, Michael Gebhart, Ahmad Awada, Novel treatment strategies for soft tissue sarcoma, Critical Reviews in Oncology/Hematology, 2007, 62, 1, 9

    CrossRef

  35. 35
    Abha A Gupta, Alberto S Pappo, New drugs for the treatment of metastatic or refractory soft tissue sarcomas in children, Future Oncology, 2006, 2, 5, 675

    CrossRef

  36. 36
    Katherine K. Matthay, Rhabdomyosarcoma,